CCB
TTNP

Cutter & Co Brokerage’s Titan Pharmaceuticals TTNP Stock Holding History

Cutter & Co Brokerage’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed -$2K – 302
2018
Q4 		$2K Hold
3
– – ﹤0.01% 268
2018
Q3 		$2K Hold
3
– – ﹤0.01% 281
2018
Q2 		$11K Hold
3
– – ﹤0.01% 246
2018
Q1 		$11K Hold
3
– – ﹤0.01% 251
2017
Q4 		$13K Hold
3
– – 0.01% 253
2017
Q3 		$18K Buy
+3
New +$18.6K 0.01% 261

Other funds holding TTNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cutter & Co Brokerage's TTNP Position: Q1 2019 in Review

Cutter & Co Brokerage sold out of Titan Pharmaceuticals (TTNP) in Q1 2019, closing a stake of 3 shares — an estimated $2K sold.

Cutter & Co Brokerage first reported a position in TTNP in Q3 2017 and held it in 6 quarters. The position peaked at $18K in Q3 2017. 15 funds tracked by Wall St. Rank hold TTNP as of Q1 2019.

  • Cutter & Co Brokerage reported no remaining Titan Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Cutter & Co Brokerage sold 3 Titan Pharmaceuticals shares in Q1 2019, an estimated $2K.
  • Cutter & Co Brokerage first reported a position in Titan Pharmaceuticals in Q3 2017 and held it in 6 quarters.
  • Cutter & Co Brokerage's Titan Pharmaceuticals position peaked at $18K in Q3 2017.
  • 15 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2019.

Based on Cutter & Co Brokerage's 13F filing for Q1 2019, filed 23 Apr 2019.